| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 1,107,074 | 556,483 | | Cost of Revenue | 868,216 | 425,312 | | | Gross Profit | 238,858 | 131,171 | | | Operating Expenses | | Research Development | 8,391 | 2,405 | | Selling General and Administrative | 61,423 | 35,609 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 169,044 | 93,157 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,956) | (2,610) | | Earnings Before Interest And Taxes | 161,769 | 90,395 | | Interest Expense | 21,868 | 8,888 | | Income Before Tax | 139,901 | 81,507 | | Income Tax Expense | (819) | 1,772 | | Minority Interest | (42,990) | (26,405) | | | | Net Income From Continuing Ops | 97,730 | 53,330 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 97,730 | 53,330 | | Preferred Stock And Other Adjustments |
-
| (7,286) | | | Net Income Applicable To Common Shares | $97,730 | $46,044 |
|
0.29% Nasdaq 
Income Statement
